TMCnet News
IGM Biosciences to Present at the 2024 RBCCM Global Healthcare ConferenceMOUNTAIN VIEW, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that management will participate in a fireside chat at the 2024 RBCCM Global Healthcare Conference on Tuesday, May 14, 2024, at 2:35 p.m. EDT. A live webcast of the event will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investor.igmbio.com/news-nd-events/events-and-presentations. A replay of the webcast will be archived on the Company’s website for 90 days following the presentation. About IGM Biosciences, Inc. Contact:
|